Selenium and Coronary Artery Disease: Should we supplement high risk patients?

Recruiting

• Conditions: Coronary Artery Disease; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12605000412639
• Lead Sponsor: Dr Nathalie van Havre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

3 vessel disease proven by angiography, with no percutaneous or surgical intervention since diagnosis.

Exclusion Criteria

Valvular heart disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death[Measured during the intervention period];Myocardial infarction[Measured during the intervention period];Early surgical or percutaneous intervention due to cardiac deterioration[Measured during the intervention period]

Secondary Outcome Measures

Name	Time	Method
Selenium level and glutathione peroxidase activity.[At baseline and 3 months.]